wheez
childhood
becom
progress
common
caus
visit
physician
emerg
room
hospit
increas
may
reflect
misdiagnos
overanxi
parent
shortag
breath
unfit
children
howev
larg
major
children
receiv
treatment
object
evid
asthma
audibl
wheez
chest
examin
revers
chang
expiratori
flow
bronchial
hyperreact
bhr
larg
proport
children
also
indirect
evid
inflamm
includ
elev
exhal
nitric
oxid
lower
ph
lung
condens
peripher
blood
eosinophilia
well
evid
allerg
sensit
gener
accept
asthma
inflammatori
diseas
came
partli
biopsi
studi
significantli
evid
steroid
treatment
effect
revers
bhr
prolong
allergen
avoid
fact
lung
inflamm
attack
asthma
caus
allergen
exposur
undoubt
mani
children
awar
acut
episod
relat
visit
hous
anim
addit
bronchial
challeng
induc
eosinophil
infiltr
lung
prolong
increas
bhr
well
acut
chang
forc
expiratori
volum
second
fev
inde
consist
method
induc
inflamm
lung
put
allergen
lung
allerg
subject
howev
bronchial
challeng
segment
challeng
natur
exposur
quantiti
allergen
inhal
much
greater
number
particl
size
particl
dramat
differ
natur
form
exposur
allergen
rel
small
number
particl
diamet
inhal
prolong
period
ie
month
year
round
small
proport
natur
occur
attack
asthma
appear
directli
relat
increas
exposur
appear
like
allergen
exposur
play
chronic
role
maintain
bronchial
inflamm
reactiv
although
mani
differ
foreign
protein
give
rise
sensit
select
group
domin
epidemiolog
asthma
group
includ
mite
cat
dog
cockroach
fungu
alternaria
main
characterist
protein
sourc
may
fact
exposur
perenni
howev
recent
evid
suggest
allergen
equal
either
properti
protein
natur
particl
may
influenc
immun
respons
suffici
influenc
preval
titer
immunoglobulin
e
ige
antibodi
respons
understand
immunopathogenesi
asthma
import
intellectu
taken
account
hypothes
increas
asthma
addit
understand
immunopathogenesi
import
part
rational
allergenspecif
treatment
pharmacolog
antiinflammatori
treatment
although
shortterm
increas
allergen
exposur
thought
import
precipit
acut
episod
asthma
strong
associ
immedi
hypersensit
acut
episod
part
may
reflect
increas
bhr
associ
elev
ige
ige
antibodi
signific
may
recent
evid
impact
rhinoviru
infect
lung
strongli
relat
elev
ige
elev
ige
antibodi
relationship
allergen
allergen
sensit
asthma
evid
allergen
play
causal
role
asthma
come
wide
varieti
experi
box
howev
primari
evid
concern
associ
sensit
asthma
studi
case
control
popul
base
prospect
case
evid
sensit
come
measur
ige
antibodi
immedi
respons
skin
test
although
implic
studi
allergen
enter
lung
play
import
role
lung
inflamm
minor
studi
show
clear
dose
respons
exposur
asthma
symptom
hand
studi
show
relationship
inhal
allergen
asthma
nonallerg
individu
like
explan
doserespons
data
ie
lack
simpl
dose
respons
relationship
come
effect
sensit
inaccuraci
measur
allergen
exposur
differ
allergen
sourc
fact
acut
episod
probabl
episod
wheez
trigger
one
mani
nonspecif
factor
contribut
symptom
fig
dozen
hundr
sourc
allergen
associ
asthma
howev
common
enough
play
role
epidemiolog
studi
either
perenni
indoor
allergen
long
season
tabl
first
studi
use
hous
dust
skin
test
imposs
defin
extract
difficult
take
result
serious
discoveri
definit
hous
dust
mite
critic
event
understand
pathogenesi
asthma
voorhorst
spieksmah
identifi
dermatophagoid
pteronyssinu
dust
develop
skin
test
reagent
rapidli
becam
obviou
dust
mite
extraordinarili
import
caus
sensit
countri
humid
high
enough
support
growth
reason
dust
mite
import
still
clear
could
reflect
presenc
bed
natur
particl
becom
airborn
biochemicalimmunolog
natur
allergen
factor
present
particl
eg
endotoxin
allergen
appear
play
import
role
asthma
includ
cat
dog
rodent
cockroach
predominantli
insid
hous
although
pollen
import
sourc
sensit
caus
asthma
season
asthma
gener
less
sever
often
consist
one
year
next
sensit
fungi
also
observ
children
asthma
howev
great
problem
consist
fungal
extract
consist
method
measur
mold
allergen
indoor
mold
thought
play
import
role
childhood
asthma
alternaria
aspergillu
obviou
common
featur
allergen
list
tabl
perenni
case
mean
indoor
may
true
fungi
inhal
dust
mite
cockroach
allergen
thought
larg
patient
hous
mani
year
assum
signific
exposur
indoor
allergen
occur
home
concept
revis
clear
signific
exposur
cat
mite
allergen
occur
outsid
child
home
cat
dog
signific
allergen
present
school
also
hous
cat
furthermor
extens
evid
quantiti
found
away
anim
suffici
sensit
inde
recent
studi
children
skin
test
posit
cat
allergen
never
live
hous
cat
messag
prevent
primari
exposur
anim
dander
possibl
dust
mite
allergen
wide
distribut
away
site
mite
growth
children
may
get
high
exposur
daycar
center
granni
hous
effect
exposur
mite
outsid
child
hous
week
two
exposur
daycar
day
week
known
howev
one
explan
lack
success
primari
avoid
studi
sensit
occur
outsid
hous
recent
studi
suggest
avoid
measur
home
prevent
lung
effect
sensit
even
prevent
sensit
import
cockroach
sourc
allergen
unit
state
becom
obviou
publish
data
relat
cockroachderiv
allergen
patient
home
bedroom
hand
well
recogn
mani
children
spend
time
live
hous
friend
rel
particularli
common
among
children
citi
implic
exposur
outsid
child
normal
home
could
relev
sensit
ongo
symptom
past
year
larg
number
protein
identifi
clone
mani
case
protein
show
sequenc
figur
immun
respons
allergen
requir
exposur
time
cours
dose
respons
variabl
respons
asymptomat
continu
exposur
allergen
give
rise
inflamm
respons
enhanc
diesel
particul
endotoxin
rhinoviru
infect
inflamm
necessarili
associ
symptom
patient
increas
bhr
bronchospasm
easili
trigger
homolog
protein
defin
function
eg
proteinas
transport
protein
profilin
import
rememb
sequenc
homolog
defin
function
enzym
activ
particular
complet
lost
minor
chang
structur
hand
mite
allergen
der
cystein
proteas
act
mani
protein
includ
although
protein
cleav
biolog
relev
surfac
antigen
open
tight
junction
vitro
much
difficult
establish
activ
relev
allergen
certainli
enzym
activ
necessari
properti
allergen
sinc
mani
major
allergen
enzym
eg
fel
der
p
bla
g
recent
evid
mechan
toler
cat
allergen
suggest
structur
allergen
signific
howev
clear
whether
reflect
primari
structur
tertiari
structur
biolog
properti
allergen
allergen
protein
physic
properti
common
particular
molecular
weight
gener
kd
addit
protein
almost
freeli
solubl
aqueou
solut
antigen
foreign
thu
simpl
view
protein
solubl
inhal
could
give
rise
ige
antibodi
respons
children
thu
could
becom
allergen
past
year
becom
clear
allergen
creat
equal
satur
vapor
pressur
molecul
size
allergen
close
zero
thu
airborn
exposur
allergen
form
particl
dramat
differ
one
sourc
anoth
outdoor
air
particl
identifi
microscop
eg
pollen
grain
fungal
spore
area
regular
count
pollen
grain
mold
spore
report
public
contrast
particl
mite
cat
dog
cockroach
allergen
becom
airborn
reliabl
identifi
microscop
fig
scienc
indoor
allergen
depend
sensit
assay
major
allergen
see
tabl
situat
made
difficult
particl
defin
two
major
indoor
allergen
airborn
transient
disturb
airborn
behavior
particl
size
allergen
content
estim
mani
allergen
tabl
aerodynam
size
particl
defin
speed
particl
fall
still
air
ie
indoor
also
relev
deposit
particl
respiratori
tract
tradit
consid
particl
larger
diamet
nonrespir
howev
term
came
research
mine
industri
nonrespir
meant
particl
would
reach
alveoli
mani
inorgan
particl
thought
deposit
alveoli
caus
maximum
damag
contrast
larger
particl
reach
tracheobronchi
tree
situat
complex
size
particl
invers
relat
proport
particl
enter
lung
hand
quantiti
allergen
per
particl
increas
cube
diamet
thu
although
particl
diamet
enter
lung
may
effect
method
deliv
protein
bronchi
particl
approxim
enter
lung
volum
thu
quantiti
protein
particl
thu
although
mite
fecal
particl
pollen
grain
larg
may
effect
method
deliv
allergen
lung
particularli
quiet
mouth
breath
although
mold
spore
gener
consid
outdoor
allergen
indoor
exposur
may
also
relev
long
period
time
spent
indoorson
averag
hour
per
day
thu
sporesm
indoor
may
signific
sporesm
outdoor
particl
size
may
import
strikingli
alternaria
spore
larger
fungal
spore
associ
strongli
asthma
southwest
midwest
unit
state
mold
spore
differ
pollen
grain
mite
fecal
particl
cat
dander
cockroach
debri
firm
outer
surfac
design
resist
desicc
result
releas
protein
rapidli
inde
major
allergen
aspergillu
express
spore
germin
import
differ
particl
appreci
compar
mite
fecal
particl
cat
dander
aspergillu
spore
see
tabl
characterist
particl
carri
allergen
dictat
total
quantiti
inhal
also
speed
releas
local
quantiti
allergen
releas
site
deposit
whether
properti
contribut
differ
immun
respons
remain
determin
howev
major
differ
allergen
relev
preval
sensit
natur
symptom
children
rais
hous
cat
increas
risk
sensit
inde
mani
studi
presenc
cat
hous
lead
decreas
risk
sensit
cat
allergen
seen
casecontrol
studi
compar
populationbas
studi
studi
popul
show
children
rais
countri
highest
percentag
cat
ownership
lower
preval
skin
sensit
ige
antibodi
cat
becom
particularli
obviou
compar
ige
antibodi
cat
ige
antibodi
mite
hand
countri
cat
sensit
import
correl
asthma
cat
ownership
decreas
risk
asthma
import
differ
studi
relat
cat
ownership
may
reflect
differ
dose
time
exposur
howev
may
also
complex
issu
relationship
differ
allergen
concomit
effect
endotoxin
exposur
three
major
propos
explain
cat
paradox
effect
due
revers
causat
ie
allerg
famili
avoid
own
cat
presenc
cat
dog
increas
level
bacteri
contamin
hous
measur
endotoxin
highdos
exposur
cat
allergen
fel
ie
presenc
cat
hous
induc
allergenspecif
form
immunolog
toler
investig
cat
paradox
carri
countri
differ
climat
hous
condit
furnish
extrem
may
instruct
northern
scandinavia
cat
allergen
import
caus
sensit
virtual
sensit
mite
cockroach
children
becom
allerg
cat
becom
asthmat
never
live
hous
cat
environ
cat
ownership
lead
decreas
allergi
decreas
preval
asthma
decreas
incid
asthma
contrast
environ
high
concentr
mite
allergen
hous
ie
unit
kingdom
australia
new
zealand
southeastern
unit
state
sensit
dust
mite
domin
form
sensit
childhood
result
presenc
cat
effect
preval
asthma
addit
presenc
cat
effect
preval
sensit
dust
mite
thu
cat
exposur
induc
specif
form
toler
implic
phenomenon
go
beyond
relev
cat
hous
allergen
distinct
abil
sensit
also
abil
toler
high
dose
produc
igg
antibodi
cat
allergen
fel
creat
risk
symptom
exposur
cat
allergen
argu
strongli
ige
antibodi
essenti
respons
give
rise
asthma
fig
effect
cat
ownership
ascrib
nonspecif
effect
sensit
ige
antibodi
product
cat
ownership
decreas
ige
antibodi
dust
mite
compar
ige
antibodi
respons
dust
mite
cat
preval
ige
antibodi
mite
higher
titer
ige
antibodi
mite
much
higher
addit
mean
total
ige
higher
cohort
children
rais
question
whether
specif
ige
respons
increas
total
present
evid
unclear
preval
wheez
children
total
ige
greater
iuml
far
higher
countri
dust
mite
domin
sourc
allergen
relev
elev
total
ige
clear
prospect
studi
emerg
room
hospit
data
sever
differ
studi
increas
risk
acut
episod
asthma
seen
either
total
serum
ige
elev
specif
ige
antibodi
greater
iuml
viral
infect
seen
precipit
asthma
either
prospect
studi
wheez
children
casecontrol
studi
emerg
room
hospit
result
show
unequivoc
viral
infect
import
precipit
acut
episod
howev
data
children
younger
year
strikingli
differ
data
older
children
younger
year
possibl
identifi
one
virus
larg
proport
children
present
admit
hospit
acut
episod
asthma
bronchiol
fig
includ
respiratori
syncyti
viru
rsv
influenza
coronaviru
also
rhinoviru
newli
describ
metapneumoviru
age
symptomat
children
allerg
agematch
children
without
respiratori
symptom
admit
emerg
room
hospit
inde
one
studi
mean
total
ige
children
admit
hospit
iuml
among
children
older
year
also
young
adult
data
complet
differ
rhinoviru
viru
shown
associ
acut
episod
children
highli
allerg
inde
mean
total
ige
children
admit
hospit
asthma
year
age
approxim
iuml
valu
control
approxim
iuml
similar
data
seen
studi
unit
kingdom
question
rhinoviru
precipit
acut
episod
wheez
respons
strongli
associ
allergi
understand
mechan
rhinoviru
induc
acut
episod
asthma
allerg
children
obtain
observ
studi
challeng
studi
evid
emerg
room
studi
children
present
elev
peripher
blood
nasal
eosinophil
well
elev
exhal
nitric
oxid
lower
ph
exhal
condens
featur
induc
degre
rhinoviru
challeng
nonsymptomat
asthmat
studi
done
children
use
nih
definit
children
ie
year
howev
strike
respons
rhinoviru
challeng
much
mark
among
asthmat
total
ige
greater
iuml
nonasthmat
individu
cours
rhinoviru
primarili
pathogen
nose
extrem
unusu
caus
pneumonia
thu
two
possibl
explan
first
rhinoviru
enter
lung
suffici
caus
increas
symptom
patholog
allerg
individu
second
event
nose
trigger
event
lung
neurolog
cellular
cytokinemedi
effect
studi
dr
buss
group
madison
establish
beyond
doubt
rhinoviru
infect
alter
respons
lung
allergen
challeng
also
argu
viru
identifi
lung
use
revers
transcriptas
polymeras
chain
reaction
surprisingli
repeat
nasal
allergen
challeng
prior
rhinoviru
challeng
increas
either
sever
cold
lung
respons
given
appar
effect
total
ige
risk
asthma
differ
effect
allergen
total
ige
could
ask
whether
allergen
increas
risk
acut
episod
preliminari
evid
suggest
acut
episod
hospit
asthma
less
common
countri
hous
dust
mite
allergen
equal
children
make
igg
antibodi
respons
without
ige
antibodi
low
mean
level
total
ige
ie
iuml
associ
risk
wheez
littl
doubt
inflamm
lung
contribut
asthma
symptom
revers
chang
lung
function
inde
shown
prolong
allergen
avoid
steroid
treatment
decreas
inflamm
lung
parallel
improv
asthma
thu
allergen
avoid
steroid
decreas
symptom
improv
lung
function
decreas
bronchial
hyperreact
bhr
clear
much
differ
element
predominantli
allergeninduc
inflamm
contribut
bhr
chang
lung
function
convinc
associ
symptom
presenc
peripher
blood
eosinophil
presenc
eosinophil
nose
given
evid
eosinophil
granul
content
eg
major
basic
protein
mbp
eosinophil
cation
protein
ecp
toxic
bronchial
epithelium
seem
logic
eosinophil
play
major
role
inflamm
asthma
surprisingli
treatment
success
reduc
peripher
blood
eosinophil
count
improv
asthma
symptom
consider
attent
focus
sequenc
event
lead
deposit
collagen
basement
membran
children
asthma
chang
associ
term
remodel
howev
term
avoid
wide
misinterpret
remodel
use
impli
progress
declin
lung
function
collagen
deposit
increas
goblet
cell
fibroblast
activ
chang
elast
lung
unfortun
clear
studi
connect
inflammatori
chang
decreas
lung
function
furthermor
littl
evid
progress
declin
lung
function
import
featur
asthma
childhood
studi
patient
present
lower
averag
lung
function
maintain
decreas
lung
function
long
period
time
childhood
asthma
manag
program
studi
littl
evid
declin
lung
function
year
furthermor
benefici
effect
inhal
steroid
control
diseas
highli
signific
result
signific
differ
lung
function
month
stop
treatment
thu
evid
inflammatori
chang
lead
progress
chang
lung
function
clear
term
remodel
avoid
hand
fact
inhal
steroid
provid
effect
control
mild
moder
asthma
argu
strongli
inflamm
play
ongo
role
symptom
howev
steroid
wide
rang
action
efficaci
provid
evid
part
inflammatori
respons
relev
primari
epidemiolog
evid
link
allergen
asthma
relat
skin
test
serum
ige
antibodi
howev
ige
antibodi
product
tcell
depend
immun
respons
allergen
also
includ
igg
iga
antibodi
could
argu
associ
ige
seen
clearli
form
sensit
easi
detect
ie
radioallergosorb
test
rast
vitro
skin
test
vivo
mani
studi
howev
tcell
respons
igg
antibodi
allergen
found
nonallerg
nonwheez
children
thu
good
reason
focu
role
immedi
ie
igemedi
hypersensit
allergen
challeng
lung
allerg
subject
produc
immedi
ie
within
minut
declin
fev
late
respons
eosinophil
infiltr
prolong
increas
bhr
mast
cell
releas
histamin
cystinyl
leukotrien
platelet
activ
factor
paf
also
cytokin
includ
chemokin
sever
recent
develop
relat
directli
understand
role
immun
respons
inflamm
symptom
respons
lung
intraderm
inject
allergen
deriv
peptid
react
directli
cell
moder
sever
asthma
evid
children
make
igg
antibodi
cat
allergen
without
ige
antibodi
increas
risk
asthma
although
current
avail
treatment
extens
evid
inject
peptid
deriv
fel
induc
delay
ie
within
hour
respons
lung
benefici
effect
symptom
result
strongli
support
view
cell
lung
contribut
patholog
asthma
howev
date
studi
conduct
allerg
subject
thu
two
question
first
quantiti
peptid
reach
lung
realist
model
could
happen
natur
exposur
second
cell
get
lung
lymphocyt
recruit
site
local
inflamm
follow
presenc
foreign
antigen
thu
attract
argument
children
ige
antibodi
local
deposit
allergen
particl
trigger
mast
cell
degranul
lead
recruit
varieti
cell
includ
lymphocyt
cell
short
live
tissu
howev
cell
recruit
tissu
may
persist
local
presenc
cell
lung
allerg
patient
could
explain
mani
featur
chronic
asthma
howev
hypothesi
cell
accumul
local
children
alreadi
immedi
hypersensit
inject
polyclon
antiig
skin
produc
wheal
flare
reaction
subject
except
small
number
igedefici
patient
hypogammaglobulinemia
thu
treatment
antiig
bind
main
epitop
epsilon
heavi
chain
possibl
howev
antibodi
site
bind
receptor
ige
bind
ige
bound
mast
cell
basophil
treatment
monoclon
antibodi
ige
would
seem
logic
treatment
allerg
diseas
howev
reason
succeed
first
monoclon
antibodi
use
clinic
act
cytokin
interleukin
present
much
smaller
quantiti
second
short
halflif
ige
mean
antibodi
pass
rapidli
circul
remain
much
longer
period
ie
week
mast
cell
skin
third
discuss
seem
like
least
part
inflammatori
respons
lung
mediat
cell
ie
depend
ige
antibodi
given
potenti
problem
success
antiig
treatment
clinic
trial
encourag
inde
children
deriv
major
benefit
form
treatment
implic
ige
antibodi
play
role
persist
inflamm
bhr
lung
find
signific
clinic
also
provid
proof
concept
ige
antibodi
play
direct
role
asthma
children
rais
hous
cat
less
like
develop
ige
antibodi
cat
allergen
mani
children
made
igg
antibodi
respons
cat
allergen
fel
without
ige
antibodi
relev
present
discuss
igg
antibodi
respons
creat
risk
wheez
thu
children
live
hous
cat
high
exposur
cat
allergen
develop
symptom
unless
immun
respons
includ
ige
antibodi
furthermor
nonallerg
subject
mount
tcell
respons
similar
respons
observ
allerg
children
implic
cell
play
role
also
ige
antibodi
respons
could
mean
either
cell
subtl
differ
ige
antibodi
necessari
cell
recruit
lung
chang
lung
children
asthma
includ
cellular
infiltr
excess
mucu
product
collagen
deposit
irrit
smooth
muscl
mechan
respons
includ
cascad
leukotrien
prostaglandin
cytokin
chemokin
mani
identifi
potenti
target
treatment
howev
given
number
molecul
identifi
difficult
establish
role
lung
respons
mani
differ
approach
use
includ
measur
cytokin
sampl
obtain
lung
gene
express
studi
detail
studi
murin
model
develop
antagonist
monoclon
antibodi
suitabl
clinic
trial
ultim
clinic
trial
provid
convinc
evid
thu
efficaci
leukotrien
antagonist
strongli
support
role
molecul
asthma
result
studi
receptor
antagonist
posit
moder
sever
asthma
unconvinc
mild
persist
asthma
year
ago
result
antagonist
paf
consist
neg
sever
target
investig
abandon
pharmaceut
industri
continu
success
corticosteroid
either
local
system
drug
may
reflect
fact
influenc
express
multipl
gene
well
dramat
reduc
circul
tissu
eosinophil
seem
obviou
corticosteroid
clinic
effect
multipl
action
agent
may
need
combin
eg
antagonist
howev
experi
kind
would
difficult
carri
clinic
trial
treatment
asthma
children
older
year
focus
longterm
antiinflammatori
treatment
strategi
recogn
larg
major
children
inflamm
medium
larg
bronchi
respons
major
caus
revers
airflow
obstruct
addit
mani
children
allerg
one
allergen
found
home
area
live
well
establish
inhal
allergen
allergen
challeng
induc
eosinophilrich
cellular
infiltr
prolong
increas
nonspecif
bhr
thu
logic
case
inhal
allergen
caus
sensit
also
diseas
view
support
result
allergen
avoid
studi
hand
difficult
establish
simpl
dose
respons
allergen
exposur
preval
sever
asthma
howev
complex
relationship
allergen
asthma
see
fig
would
tend
obscur
dose
respons
simpl
relationship
exposur
patient
home
wheez
could
obscur
genet
inaccuraci
floor
dust
assay
measur
inhal
exposur
exposur
indoor
allergen
build
child
home
toler
allergen
high
dose
viru
infect
play
import
role
bronchiol
wheezingasthma
throughout
childhood
children
younger
year
mani
differ
virus
induc
bronchiol
age
rsv
influenza
metapneumoviru
rhinoviru
may
play
role
major
defin
risk
factor
viralinduc
wheez
episod
children
younger
year
small
lung
size
birth
age
allergi
play
signific
role
mani
children
earli
viralinduc
episod
go
persist
asthma
howev
earli
episod
common
clear
whether
earli
infect
influenc
subsequ
develop
allergi
persist
asthma
age
year
role
viral
infect
chang
complet
presum
lung
growth
viral
infect
nonallerg
children
longer
caus
emerg
room
hospit
visit
age
viru
appear
play
import
role
rhinoviru
effect
seen
allerg
children
significantli
children
simpli
skin
test
posit
major
elev
total
serum
ige
geometr
mean
valu
children
age
year
iuml
result
consist
studi
suggest
condit
increas
total
ige
could
risk
factor
sever
episod
asthma
elev
total
ige
strongli
associ
asthma
burrow
colleagu
report
higher
total
ige
greater
preval
asthma
clearli
shown
total
ige
strongli
influenc
genet
howev
recent
studi
suggest
allergen
contribut
other
particular
dust
mite
cockroach
grass
pollen
fungu
alternaria
shown
induc
hightit
ige
antibodi
ie
iuml
instanc
increas
total
serum
ige
contrast
cat
dog
allergen
posit
skin
test
less
common
titer
ige
antibodi
gener
lower
thu
allergen
other
increas
total
ige
level
associ
acut
episod
effect
may
contribut
higher
preval
sever
asthma
commun
eg
new
zealand
unit
kingdom
north
american
inner
citi
compar
other
eg
scandinavia
relev
immunopathogenesi
treatment
seen
three
way
first
control
inflammatori
respons
becom
mainstay
treatment
use
inhal
steroid
leukotrien
antagonist
small
number
case
antiig
second
allergenspecif
treatment
use
avoid
immunotherapi
influenc
inflamm
lung
third
futur
approach
therapi
could
focu
alter
immun
respons
use
peptid
recombin
molecul
influenc
tcell
respons
ige
antibodi
product
given
complex
immun
respons
allergen
relationship
symptom
surpris
analysi
genet
asthma
provid
inconsist
result
presum
environment
effect
relat
time
cours
dose
differ
allergen
well
modul
effect
endotoxin
exposur
alter
associ
differ
gene
addit
effect
mani
differ
chang
lifestyl
may
also
influenc
relationship
implic
focu
interpret
alter
inflammatori
respons
environ
